235 related articles for article (PubMed ID: 26969580)
1. Interleukin-33: increasing role in dermatological conditions.
Balato A; Raimondo A; Balato N; Ayala F; Lembo S
Arch Dermatol Res; 2016 Jul; 308(5):287-96. PubMed ID: 26969580
[TBL] [Abstract][Full Text] [Related]
2. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
3. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
Chen WY; Li LC; Yang JL
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33 and Behçet disease: Another cytokine among others.
Hamzaoui K; Bouali E; Hamzaoui A
Hum Immunol; 2015 May; 76(5):301-6. PubMed ID: 25814446
[TBL] [Abstract][Full Text] [Related]
6. IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.
Du LX; Wang YQ; Hua GQ; Mi WL
Neuroscience; 2018 Jan; 369():222-230. PubMed ID: 29175156
[TBL] [Abstract][Full Text] [Related]
7. Effects of IL-33/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile.
Stankovic MS; Janjetovic K; Velimirovic M; Milenkovic M; Stojkovic T; Puskas N; Zaletel I; De Luka SR; Jankovic S; Stefanovic S; Japundzic-Zigon N; Petronijevic ND; Trajkovic V; Trbovich AM
Exp Mol Pathol; 2016 Aug; 101(1):31-7. PubMed ID: 27222019
[TBL] [Abstract][Full Text] [Related]
8. IL-33/ST2 Axis Plays a Protective Effect in
Kuo CF; Chen WY; Yu HH; Tsai YH; Chang YC; Chang CP; Tsao N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638904
[TBL] [Abstract][Full Text] [Related]
9. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
10. Targeting IL-33/ST2 signaling: regulation of immune function and analgesia.
Fattori V; Hohmann MSN; Rossaneis AC; Manchope MF; Alves-Filho JC; Cunha TM; Cunha FQ; Verri WA
Expert Opin Ther Targets; 2017 Dec; 21(12):1141-1152. PubMed ID: 29076792
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 in Malignancies: Friends or Foes?
Shen JX; Liu J; Zhang GJ
Front Immunol; 2018; 9():3051. PubMed ID: 30619376
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33, friend and foe in type-2 immune responses.
Hardman C; Ogg G
Curr Opin Immunol; 2016 Oct; 42():16-24. PubMed ID: 27254379
[TBL] [Abstract][Full Text] [Related]
13. Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury.
Chen WY; Li LC; Wu YH; Yang JL; Tzeng HT
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102434
[TBL] [Abstract][Full Text] [Related]
14. IL-33/ST2 Axis in Organ Fibrosis.
Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
Front Immunol; 2018; 9():2432. PubMed ID: 30405626
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.
Sun Y; Wen Y; Wang L; Wen L; You W; Wei S; Mao L; Wang H; Chen Z; Yang X
Front Immunol; 2021; 12():654626. PubMed ID: 34079543
[TBL] [Abstract][Full Text] [Related]
16. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy.
Liu B; Tai Y; Achanta S; Kaelberer MM; Caceres AI; Shao X; Fang J; Jordt SE
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7572-E7579. PubMed ID: 27821781
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
[TBL] [Abstract][Full Text] [Related]
18. Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.
Abd Rachman Isnadi MF; Chin VK; Abd Majid R; Lee TY; Atmadini Abdullah M; Bello Omenesa R; Osamah Ibraheem Z; Basir R
Mediators Inflamm; 2018; 2018():5346413. PubMed ID: 29507527
[TBL] [Abstract][Full Text] [Related]
19. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation.
Lin L; Li Y; Liu M; Li Q; Liu Q; Li R
Aging (Albany NY); 2020 Jan; 12(2):1685-1703. PubMed ID: 32003751
[TBL] [Abstract][Full Text] [Related]
20. The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox.
Allegra A; Innao V; Tartarisco G; Pioggia G; Casciaro M; Musolino C; Gangemi S
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
